Home > Qtrly Results > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Quarterly Results Analysis [Sep2026]

EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Quarterly Results

Consolidated Sep2026
UnAudited
Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Revenues ₹2,820 Cr ₹2,580 Cr ₹2,470 Cr ₹2,363 Cr ₹2,270 Cr ₹2,101 Cr ₹2,116 Cr ₹1,963 Cr
Expenses ₹2,233 Cr ₹2,048 Cr ₹1,990 Cr ₹1,871 Cr ₹1,794 Cr ₹1,684 Cr ₹1,714 Cr ₹1,608 Cr
Operating Income ₹588 Cr ₹532 Cr ₹480 Cr ₹493 Cr ₹475 Cr ₹417 Cr ₹402 Cr ₹355 Cr
Other Income ₹3 Cr ₹2 Cr ₹4 Cr ₹2 Cr ₹3 Cr ₹4 Cr ₹4 Cr ₹4 Cr
Interest ₹36 Cr ₹32 Cr ₹46 Cr ₹38 Cr ₹33 Cr ₹27 Cr ₹39 Cr ₹32 Cr
Depreciation ₹110 Cr ₹110 Cr ₹106 Cr ₹105 Cr ₹105 Cr ₹99 Cr ₹97 Cr ₹97 Cr
Profit Before Tax ₹446 Cr ₹394 Cr ₹341 Cr ₹314 Cr ₹341 Cr ₹291 Cr ₹261 Cr ₹230 Cr
Profit After Tax ₹325 Cr ₹292 Cr ₹244 Cr ₹231 Cr ₹251 Cr ₹215 Cr ₹197 Cr ₹156 Cr
EPS ₹17.16 ₹15.50 ₹12.84 ₹12.16 ₹12.84 ₹10.92 ₹9.97 ₹8.11
Industry Peers & Returns1W1M1Y
EMCURE PHARMACEUTICALS 15.1% 23.3% 67.1%
SUN PHARMACEUTICAL INDUSTRIES 8.1% 9.3% 9%
DIVIS LABORATORIES 10.5% 18% 51.4%
TORRENT PHARMACEUTICALS 2.9% 2.1% 30.7%
CIPLA 1.4% 8.1% -6.8%
DR REDDYS LABORATORIES -0.1% 16% 14.6%
MANKIND PHARMA 4% 7.5% 5.8%
LUPIN -0.8% 2.7% 0.2%
ZYDUS LIFESCIENCES -3.2% 7.6% 21.9%

EMCURE PHARMACEUTICALS Quarterly Revenues

Revenues
Q-o-Q

9.30 %

Y-o-Y

24.26 %

Quarters Revenues % Change
Sep2026 ₹2,820 Cr
9.30
Jun2026 ₹2,580 Cr
4.48
Mar2026 ₹2,470 Cr
4.49
Dec2025 ₹2,363 Cr
4.13
Sep2025 ₹2,270 Cr
8.06
Jun2025 ₹2,101 Cr
-0.74
Mar2025 ₹2,116 Cr
7.83
Dec2024 ₹1,963 Cr -

EMCURE PHARMACEUTICALS Quarterly Operating Profit

Operating Profit
Q-o-Q

10.39 %

Y-o-Y

23.63 %

Quarters Operating Profit % Change
Sep2026 ₹588 Cr
10.39
Jun2026 ₹532 Cr
11.04
Mar2026 ₹480 Cr
-2.68
Dec2025 ₹493 Cr
3.63
Sep2025 ₹475 Cr
14.09
Jun2025 ₹417 Cr
3.57
Mar2025 ₹402 Cr
13.48
Dec2024 ₹355 Cr -
Operating Margins
Q-o-Q

0.97 %

Y-o-Y

-0.53 %

Quarters Operating Margin% % Change
Sep2026 20.84%
0.97
Jun2026 20.64%
6.28
Mar2026 19.42%
-6.86
Dec2025 20.85%
-0.48
Sep2025 20.95%
5.59
Jun2025 19.84%
4.37
Mar2025 19.01%
5.20
Dec2024 18.07% -

EMCURE PHARMACEUTICALS Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

11.14 %

Y-o-Y

29.32 %

Quarters Profit After Tax % Change
Sep2026 ₹325 Cr
11.14
Jun2026 ₹292 Cr
20.00
Mar2026 ₹244 Cr
5.34
Dec2025 ₹231 Cr
-7.96
Sep2025 ₹251 Cr
17.03
Jun2025 ₹215 Cr
8.90
Mar2025 ₹197 Cr
26.36
Dec2024 ₹156 Cr -
PAT Margins
Q-o-Q

1.77 %

Y-o-Y

4.16 %

Quarters PAT Margin(%) % Change
Sep2026 11.53 %
1.77
Jun2026 11.33 %
14.79
Mar2026 9.87 %
0.82
Dec2025 9.79 %
-11.56
Sep2025 11.07 %
8.21
Jun2025 10.23 %
9.76
Mar2025 9.32 %
17.23
Dec2024 7.95 % -

EMCURE PHARMACEUTICALS Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

10.71 %

Y-o-Y

33.64 %

Quarters EPS % Change
Sep2026 ₹17.16
10.71
Jun2026 ₹15.5
20.72
Mar2026 ₹12.84
5.59
Dec2025 ₹12.16
-5.30
Sep2025 ₹12.84
17.58
Jun2025 ₹10.92
9.53
Mar2025 ₹9.97
22.93
Dec2024 ₹8.11 -

You may also like the below Video Courses